Interestingly, leptin, an adipocyte-derived hormone, activates the invasion of GC cells by targeting the MEK as well as the JAK-STAT pathways, which led to the preservation of stemness and metastatic capability, indicating that leptin-mediated signaling could serve as a potent therapeutic target for GC [70]. The gene discussed is MAP2K7; the disease is gastric cancer.